Adamantiades-Behçet's disease (Behçet's disease) and COVID-19
| Autor: | Christos C. Zouboulis, Giacomo Emmi, Ahmet Gül, Farida Fortune, J. A. M. van Laar, Petros P. Sfikakis, Graham R. Wallace, Farhad Shahram, Eun-So Lee, Yohei Kirino, Michael Schirmer |
|---|---|
| Přispěvatelé: | Immunology |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19) business.industry SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Behcet Syndrome COVID-19 Dermatology Disease Behcet's disease medicine.disease Organ damage Infectious Diseases Immune system SDG 3 - Good Health and Well-being Immunology Medicine Humans In patient business Letters to the Editor Letter to the Editor |
| Zdroj: | Journal of the European Academy of Dermatology and Venereology Journal of the European Academy of Dermatology and Venereology, 35(9), e541-e543. Wiley-Blackwell |
| ISSN: | 1468-3083 0926-9959 |
| Popis: | The immunopathogenesis of COVID-19 remains ill-defined. Through hyperstimulation of the immune system, SARS-CoV2 may cause a multi-facetted inflammatory disease and generate immune-mediated organ damage even leading to fatal consequences. However, it is still unclear, if a modified course of COVID-19 occurs in patients with autoimmune and/or autoinflammatory diseases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text